Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Restless leg syndrome in different types of demyelinating neuropathies: a single-center pilot study.
Placebo Cohorts in Phase-3 MS Treatment Trials - Predictors for On-Trial Disease Activity 1990-2010 Based on a Meta-Analysis and Individual Case Data.
Relationship between vitamin D and depression in multiple sclerosis.
Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress.
Deaths and disability from natalizumab are no longer tolerable: No - (they can be avoided).
Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status.
Physical fitness assessment in multiple sclerosis patients: A controlled study.
25-Hydroxycholecalciferol status in plasma is linearly correlated to daily summer pasture time in cattle at 56°N.
Navigating Life and Loss in Pediatric Multiple Sclerosis.
The effect of gabapentin on oxidative stress in a model of toxic demyelination in rat brain.
Excitotoxic mechanisms of ischemic injury in myelinated white matter.
Treatment with natalizumab in relapsing-remitting multiple sclerosis patients induces changes in inflammatory mechanism.
The role of stress-response systems for the pathogenesis and progression of MS.
Response to disease modifying therapies in African Americans with multiple sclerosis.
Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis.
Diffusion tensor imaging of the corticospinal tract and walking performance in multiple sclerosis.
Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia
FTY720 (fingolimod) modulates the severity of viral-induced encephalomyelitis and demyelination.
IFN-γ ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation.
The role of interleukin-6 signaling in nervous tissue.
The Afferent Visual Pathway: Designing a Structural-Functional Paradigm of Multiple Sclerosis.
Mechanisms in the Development of Multiple Sclerosis Lesions: Reconciling Autoimmune and Neurodegenerative Factors.
Validation and interpretation of the Dutch version of the Multiple Sclerosis Neuropsychological Screening Questionnaire.
Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations.
Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave Dreams Study (Brain Venous Drainage Exploited Against Multiple Sclerosis): study protocol for a randomized controlled trial.
Pages
« first
‹ previous
…
215
216
217
218
219
220
221
222
223
…
next ›
last »